UTAH MEDICAL PRODUCTS, INC. Selling, General and Administrative Expense
UTAH MEDICAL PRODUCTS, INC. (UTMD) reported Selling, General and Administrative Expense of $1.96 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-12
- UTAH MEDICAL PRODUCTS, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $1.96M, a 13.65% decline year-over-year.
- UTAH MEDICAL PRODUCTS, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $2.56M, a 14.88% increase year-over-year.
- UTAH MEDICAL PRODUCTS, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $2.83M, a 23.57% increase year-over-year.
- UTAH MEDICAL PRODUCTS, INC. selling, general and administrative expense for the quarter ending 2025-06-30 was $2.26M, a 11.56% decline year-over-year.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month |
|---|---|---|---|---|
| 2026-06-30 | $1.96M 10-Q · filed 2026-08-12 | $4.52M 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | $2.56M 10-Q · filed 2026-05-12 | |||
| 2025-09-30 | $2.83M 10-Q · filed 2025-11-14 | $5.09M derived: sum of 2 quarters · filed 2026-08-12 | $7.32M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $2.26M 10-Q · filed 2026-08-12 | $4.50M 10-Q · filed 2026-08-12 | ||
| 2025-03-31 | $2.23M 10-Q · filed 2026-05-12 | |||
| 2024-09-30 | $2.29M 10-Q · filed 2025-11-14 | $4.85M derived: sum of 2 quarters · filed 2025-11-14 | $7.46M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $2.56M 10-Q · filed 2025-08-12 | $5.18M 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | $2.62M 10-Q · filed 2025-05-15 | |||
| 2023-09-30 | $3.25M 10-Q · filed 2024-11-12 | $6.43M derived: sum of 2 quarters · filed 2024-11-12 | $9.69M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $3.18M 10-Q · filed 2024-08-09 | $6.44M 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $3.26M 10-Q · filed 2024-05-10 | |||
| 2022-09-30 | $2.93M 10-Q · filed 2023-11-13 | $5.89M derived: sum of 2 quarters · filed 2023-11-13 | $8.78M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $2.96M 10-Q · filed 2023-08-11 | $5.85M 10-Q · filed 2023-08-11 | ||
| 2022-03-31 | $2.89M 10-Q · filed 2023-05-05 | |||
| 2021-09-30 | $2.85M 10-Q · filed 2022-11-10 | $5.74M derived: sum of 2 quarters · filed 2022-11-10 | $8.67M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $2.89M 10-Q · filed 2022-08-12 | $5.82M 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $2.93M 10-Q · filed 2022-05-11 | |||
| 2020-09-30 | $2.79M 10-Q · filed 2021-11-12 | $5.64M derived: sum of 2 quarters · filed 2021-11-12 | $8.48M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $2.86M 10-Q · filed 2021-08-06 | $5.70M 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | $2.84M 10-Q · filed 2021-05-11 | |||
| 2019-09-30 | $2.88M 10-Q/A · filed 2020-11-09 | $5.78M derived: sum of 2 quarters · filed 2020-11-09 | $8.34M 10-Q/A · filed 2020-11-09 | |
| 2019-06-30 | $2.91M 10-Q · filed 2020-08-07 | $5.46M 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $2.56M 10-Q · filed 2020-05-08 | |||
| 2018-09-30 | $1.78M 10-Q · filed 2019-11-07 | $3.60M derived: sum of 2 quarters · filed 2019-11-07 | $5.43M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $1.81M 10-Q · filed 2019-08-09 | $3.65M 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $1.84M 10-Q · filed 2019-05-09 | |||
| 2017-09-30 | $1.71M 10-Q · filed 2018-11-07 | $3.45M derived: sum of 2 quarters · filed 2018-11-07 | $5.15M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $1.74M 10-Q · filed 2018-08-09 | $3.43M 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | $1.69M 10-Q · filed 2018-05-09 | |||
| 2016-09-30 | $1.70M 10-Q · filed 2017-11-07 | $3.52M derived: sum of 2 quarters · filed 2017-11-07 | $5.32M 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $1.82M 10-Q · filed 2017-08-03 | $3.62M 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | $1.80M 10-Q · filed 2017-05-05 | |||
| 2015-09-30 | $1.97M 10-Q · filed 2016-11-04 | $3.96M derived: sum of 2 quarters · filed 2016-11-04 | $6.04M 10-Q · filed 2016-11-04 | |
| 2015-06-30 | $1.99M 10-Q · filed 2016-08-08 | $4.07M 10-Q · filed 2016-08-08 | ||
| 2015-03-31 | $2.08M 10-Q · filed 2016-05-06 | |||
| 2014-09-30 | $2.08M 10-Q · filed 2015-11-06 | $4.25M derived: sum of 2 quarters · filed 2015-11-06 | $6.34M 10-Q · filed 2015-11-06 | |
| 2014-06-30 | $2.17M 10-Q · filed 2015-08-07 | $4.26M 10-Q · filed 2015-08-07 | ||
| 2014-03-31 | $2.08M 10-Q · filed 2015-05-06 | |||
| 2013-09-30 | $2.16M 10-Q · filed 2014-11-04 | $2.16M 10-Q · filed 2013-11-06 | $4.37M derived: sum of 2 quarters · filed 2014-11-04 | $6.64M 10-Q · filed 2014-11-04 |
| 2013-06-30 | $2.21M 10-Q · filed 2014-08-08 | $4.48M 10-Q · filed 2014-08-08 | ||
| 2013-03-31 | $2.27M 10-Q · filed 2014-05-07 | |||
| 2012-09-30 | $2.38M 10-Q · filed 2013-11-06 | $4.75M derived: sum of 2 quarters · filed 2013-11-06 | $7.23M 10-Q · filed 2013-11-06 | |
| 2012-06-30 | $2.37M 10-Q · filed 2013-08-08 | $4.85M 10-Q · filed 2013-08-08 | ||
| 2012-03-31 | $2.48M 10-Q · filed 2013-05-08 | |||
| 2011-09-30 | $2.84M 10-Q · filed 2012-11-09 | $5.72M derived: sum of 2 quarters · filed 2012-11-09 | $7.17M 10-Q · filed 2012-11-09 | |
| 2011-06-30 | $2.88M 10-Q · filed 2012-08-08 | $4.33M 10-Q · filed 2012-08-08 | ||
| 2011-03-31 | $1.45M 10-Q · filed 2012-05-09 | |||
| 2010-09-30 | $977.00K 10-Q · filed 2011-11-07 | $1.95M derived: sum of 2 quarters · filed 2011-11-07 | $2.89M 10-Q · filed 2011-11-07 | |
| 2010-06-30 | $977.00K 10-Q · filed 2011-08-08 | $1.92M 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |